Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia Efficacy of parthenolide on lung histopathology in a murine model of asthma
Journal Information
Vol. 45. Issue 1.
Pages 63-68 (January - February 2017)
Share
Share
Download PDF
More article options
ePub
Vol. 45. Issue 1.
Pages 63-68 (January - February 2017)
Original Article
DOI: 10.1016/j.aller.2016.06.005
Efficacy of parthenolide on lung histopathology in a murine model of asthma
Visits
...
Z. Arıkan-Ayyıldıza,
Corresponding author
, M. Karamanb, S. Özbalc, A. Bağrıyanıkc, O. Yilmazb, Ö. Karamana, N. Uzunera
a Department of Pediatric Allergy, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
b Department of Experimental Animal Laboratory, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
c Department of Histology and Embryology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (3)
Table 1. Schematic presentation of the experimental drugs and study drugs.
Table 2. Histological comparison of the study groups.
Table 3. Comparison of IL-4 and IL-5 between study groups.
Show moreShow less
Abstract
Background

Parthenolide is the active constituent of the plant ‘Tanacetum parthenium’ (Feverfew) which has been used for centuries as a folk remedy for inflammatory conditions.

Aim of the study

In this study we aimed to investigate the effects of parthenolide in a murine model of chronic asthma.

Materials and methods

Thirty-five BALB/c mice were divided into five groups; I (control), II (placebo), III (dexamethasone), IV (parthenolide) and V (dexamethasone and parthenolide combination). Lung histology was evaluated after treatment with the study drugs. Levels of interleukin (IL)-4 and IL-5 were determined by ELISA.

Results

Histologic parameters except the number of mast and goblet cells improved in the parthenolide group when compared with placebo. All parameters except basal membrane thickness and number of mast cells were improved significantly better in the group receiving dexamethasone when compared with the parthenolide group. Improvement of most of the histologic parameters was similar in Groups III and V. Interleukin-4 levels were significantly reduced in the parthenolide group when compared to the placebo group.

Conclusion

We demonstrated that parthenolide administration alleviated some of the pathological changes in asthma. But parthenolide alone is not efficient as dexamethasone therapy and the parthenolide and dexamethasone combination also did not add any beneficial effect to the dexamethasone treatment.

Keywords:
Asthma
Lung histology
Murine model
Parthenolide
Tanacetum Parthenium

Article

These are the options to access the full texts of the publication Allergologia et Immunopathologia
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Allergologia et Immunopathologia

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 22,50 €

Comprar ahora
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.